Health Care/Hospital

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 and Chemotherapy as Adjuvant Treatment of Breast Cancer

SUZHOU, China, March 24, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in the Phase III clinical study (KN026-007) of HER2 bispecific antibody Anbenitamab (KN026) in combination with albumin-bound docetaxel (HB1801) and chemothe...

2026-03-24 09:32 4680

Celosia Therapeutics Announces First Patient Dosed in Phase 1b Clinical Trial of CTx1000 in Amyotrophic Lateral Sclerosis

CTx1000 designed to clear pathological TDP-43 protein, a central driver of ALS SYDNEY, March 24, 2026 /PRNewswire/ -- Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, today announced dosing of the first participant in its Phas...

2026-03-24 05:30 3358

Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable

Peer-reviewed economic analysis finds a combined ESR + CRP testing strategy reduces misdiagnoses and delivers net cost savings compared to CRP alone SMITHFIELD, R.I., March 24, 2026 /PRNewswire/ -- ESR and CRP ar...

2026-03-24 04:32 3837

Sisram Medical Reports Solid Growth in 2025

Solid growth driven by strong performance in international markets, with the injectables business accelerating rapidly DAXXIFY shows promising results from initial commercialization in China, with expansion plans underway HONG KONG, March 23, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company"...

2026-03-23 22:56 5311

NYSE Content Update: Alto Neuroscience Raises $120 Million to Fund Development of ALTO-207

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, March 23, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begi...

2026-03-23 21:00 6308

Cambrex Advances US and European Expansions

EAST RUTHERFORD, N.J., March 23, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced the completion of initial engineering studies for its new, large-scale active pharmaceutical ingredient (API) manufacturing plant in Charles ...

2026-03-23 20:00 4139

Monash University and ClinChoice Forge Strategic Partnership to Accelerate Clinical Development of Innovative Therapies

MELBOURNE, Australia, March 23, 2026 /PRNewswire/ -- Monash University and ClinChoice Inc, a leading global clinical Contract Research Organization (CRO) focused on innovative therapeutics, today announced a strategic partnership designed to fast-track early-phase clinical trials and bring ground...

2026-03-23 14:15 4904

Belief BioMed and Grand Life Sciences Announced Exclusive Commercial Partnership in the Field of Hemophilia A, Bringing Innovative Gene Therapy to Chinese Patients

SHANGHAI, March 23, 2026 /PRNewswire/ -- Belief BioMed ("BBM") and Grand Life Sciences Group Co., Ltd. ("Grand Life Sciences") today announced an exclusive collaboration agreement. Under the agreement, Belief BioMed will grant Grand Life Sciences the rights to commercialize its investigational pr...

2026-03-23 14:02 5159

Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize CARDAMYST™ (Etripamil) Nasal Spray in Greater China

SHANGHAI, March 23, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into an Asset P...

2026-03-23 10:24 3841

SingWealth Holdings Strengthens Community Resilience Through Health, Wealth and Legacy Conversations at Lianhe Zaobao Event

SINGAPORE, March 23, 2026 /PRNewswire/ -- SingWealth Holdings ('SingWealth') recently stepped forward as the lead sponsor for Lianhe Zaobao'sMy Legacy and Living Well held on 21 March 2026, reinforcing the Group's commitment to helping Singaporeans navigate crit...

2026-03-23 10:00 3196

SORTIE Agency Honours Content Innovation with Kam Fan Bronze Award for Heroes in White

Redefining Brand Integration: A Strategic Narrative That Resonates with Audiences and Industry Alike HONG KONG, March 23, 2026 /PRNewswire/ -- SORTIE Agency has emerged as a standout at the 41st Kam Fan Awards, one of the advertising industry's most prestigious annual events, securing a Bronze a...

2026-03-23 09:00 2592

Quality Protein No Longer a Luxury? Angel Yeast Shows How at FIC 2026

SHANGHAI, March 20, 2026 /PRNewswire/ -- Angel Yeast (SH600298) showcased its latest yeast protein R&D achievements and progress in global applications at FIC 2026 from March 17-19, 2026, reaffirming its commitment to making high-quality protein accessible to everyon...

2026-03-20 22:52 6683

Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations

SHANGHAI, March 20, 2026 /PRNewswire/ -- Henlius (2696.HK) today announced its annual results for the year ended December 31, 2025. During the reporting period, the Company recorded revenue of RMB 6.6666 billion, representing a year-on-year increase of 16.5%, and net profit of RMB 0.8270 billion....

2026-03-20 21:21 9830

HKSH Cancer Centre's Precision Targeting Technologies Leading the Evolution of "Hypofractionation"

Asia's First Study: 5 Sessions of Proton Therapy to Control Early-Stage Prostate Cancer HONG KONG, March 20, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) today announced the results of Asia's first clinical study on early-stage prostate cancer patients receiving five-session of proton therapy....

2026-03-20 19:10 4642

Manulife Named "Asia's Best Insurance Provider for Wealth Management" by Euromoney

HONG KONG, March 20, 2026 /PRNewswire/ -- Manulife today announced it has been named "Asia's Best Insurance Provider for Wealth Management" at the 2026 Euromoney Private Banking Awards. The award recognizes Manulife's excellence in delivering tailored and innovative wealth and legacy planning sol...

2026-03-20 18:00 8085

Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability

SHANGHAI and HONG KONG, March 20, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) today announced its full-year results for the period ending December 31, 2025, and provided an update on recent business highlights and strategic progress. Dr. Jay Mei, Antengene's...

2026-03-20 17:14 7129

World Oral Health Day 2026: FDI urges governments to turn UN oral health commitments into action

Landmark UN political declaration recognizes oral health as essential to tackling noncommunicable diseases GENEVA, March 20, 2026 /PRNewswire/ -- On World Oral Health Day  (WOHD), FDI World Dental Federation (FDI) is urging governments to translate the oral h...

2026-03-20 16:30 3670

Ribo expands beyond the liver with RiboPepSTAR™ - enabling targeted siRNA delivery to multiple organs

SUZHOU, China and MÖLNDAL, Sweden, March 20, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd.  ("Ribo" or "the Company", Hong Kong Stock Exchange code: 6938) had been invited to give a speech at the RNA Leaders Europe Conference in Vienna, Austria on March 19th, one of the top oligonucleot...

2026-03-20 14:44 4676

Professor Chun-Hung Chu: "Protecting Oral Health Is Protecting Quality of Life"

World Oral Health Day 2026:"A Happy Mouth Is… A Happy Life" HONG KONG, March 20, 2026 /PRNewswire/ -- A healthy mouth is the foundation of overall well-being and plays an important role in enhancing quality of life. This year, World Oral Health Day is celebrated under the theme "A Happy Mouth Is...

2026-03-20 13:05 3429

MGI Tech and NUS Pharmacy and Pharmaceutical Sciences Announce Collaboration on DCS Lab to Accelerate Multi-Omics Innovation in Pharmaceutical Sciences

SINGAPORE, March 20, 2026 /PRNewswire/ -- MGI Tech Singapore Pte. Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and the Department of Pharmacy and Pharmaceutical Sciences in the National University of Singapore's Faculty of Sci...

2026-03-20 11:17 5284
1 ... 6789101112 ... 544

Week's Top Stories